Theme

Genomics & Biotech Innovation ETFs

Funds built around Genomics & Biotech Innovation. Pick one to see news about the companies inside it.

ARKGARK Genomic Revolution
Seeking Alpha · 28 Oct 2026, 20:19 UTC
10x Genomics: Atera Takes Off, But Valuation Flies Too High (NASDAQ:TXG) | Seeking Alpha
9.4% of ARKGMore ARKG news →
CANCTema Oncology
Quartz · 28 Oct 2026, 16:16 UTC
Best-selling drugs 2026: 7 of the top 10 by 2025 sales
11.7% of CANCMore CANC news →
GNOMGlobal X Genomics & Biotechnology
24/7 Wall St. · 28 Oct 2026, 16:04 UTC
Moderna Jumps 4% Despite William Blair Downgrade on Valuation; Novavax and BioNTech Edge Higher
6.7% of GNOMMore GNOM news →
HELXFranklin Genomic Advancements
Seeking Alpha · 28 Oct 2026, 17:33 UTC
Ligand Pharmaceuticals Q3 2026 Earnings Preview | Seeking Alpha
4.6% of HELXMore HELX news →
IBRNiShares Neuroscience and Healthcare
Seeking Alpha · 28 Oct 2026, 20:02 UTC
Biogen anticipates $250M of run rate synergies by end of 2027 as it raises 2026 non-GAAP EPS to $12.20-$13 (NASDAQ:BIIB) | Seeking Alpha
4.2% of IBRNMore IBRN news →
IDNAiShares Genomics Immunology and Healthcare
24/7 Wall St. · 28 Oct 2026, 16:04 UTC
Moderna Jumps 4% Despite William Blair Downgrade on Valuation; Novavax and BioNTech Edge Higher
13.1% of IDNAMore IDNA news →
OZEMRoundhill GLP-1 & Weight Loss
Quartz · 28 Oct 2026, 14:15 UTC
New weight-loss drugs: what 6 drugmakers are testing
35.9% of OZEMMore OZEM news →
PBEInvesco Biotechnology & Genome
Scienmag: Latest Science and Health News · 28 Oct 2026, 18:47 UTC
Nanopore Sequencing Delivers Full Pediatric Brain Tumor Workup in a Single
5.4% of PBEMore PBE news →
THNRAmplify Weight Loss Drug & Treatment
Quartz · 28 Oct 2026, 16:16 UTC
Best-selling drugs 2026: 7 of the top 10 by 2025 sales
28.0% of THNRMore THNR news →
WDNAWisdomTree BioRevolution Fund
Quartz · 28 Oct 2026, 14:15 UTC
New weight-loss drugs: what 6 drugmakers are testing
7.0% of WDNAMore WDNA news →
XDNAKelly CRISPR & Gene Editing Technology
News-Medical.net · 28 Oct 2026, 17:31 UTC
Hot-melt extrusion in pharmaceutical implant manufacturing
9.9% of XDNAMore XDNA news →